Novo Nordisk’s Oral Wegovy Wins EU Nod: Can the Pill’s US Success Scale Across 27 Markets?
For millions of Europeans who have shunned weight-loss injections, the arrival of a daily pill could change the…
Novo Nordisk’s ADA Data: One Success, One Setback, and a Stock Under Pressure
Novo Nordisk shares drop 16% YTD after CagriSema fails non-inferiority vs Lilly’s Zepbound; Zenagamtide Phase 2 shows strong…
Teen Pill Success Meets Canadian Generic Shock
Novo Nordisk celebrates positive trial results for oral semaglutide in teens while facing first generic Ozempic competition in…
Midtjylland star stabbed in Denmark as he undergoes surgery on life-threatening injuries
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Midtjylland star stabbed in Denmark as he undergoes surgery on life-threatening injuries
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Novo Nordisk’s Sickle Cell Success Charts a New Path Beyond Blockbuster Drugs
Novo Nordisk’s etavopivat reduces sickle cell crises by 27% in Phase 3 trial, marking a key diversification move…
Novo Nordisk’s Sickle Cell Success Charts a New Path Beyond Blockbuster Drugs
Novo Nordisk’s etavopivat reduces sickle cell crises by 27% in Phase 3 trial, marking a key diversification move…